- On Oct. 17, Canada lifts the bar on adult marijuana sales, unleashing a potential $5.7 billion legal weed market next year
- Investors anticipating the event have thrown so much money at Canadian MJ producers their stocks are now selling at 120X sales or higher, and in the case of one profitable company 1,900X earnings.
- We find 3 good companies that are potential bright spots in the legal marijuana market.
By most estimates, Canada’s new recreational market will be 8X bigger than its thriving medical market. But most Canadian pot stocks are selling at valuations likely to thud loudly when they fall back to earth. Canopy Growth and Aphria, for instance, both carry market caps that are bigger than the entire marijuana industry—including adult tokers.
There are still a few deals left, though. These are the handful of stocks that investors have not followed closely enough. VIVO Cannabis Inc.TM (TSXV: VIVO) (formerly ABcann Global) has a collection of premium brands across medical and recreational, with large production capabilities. Supreme Cannabis (V: FIRE) is another. It is selling at a steep discount to its peers despite a lucrative contract to sell product to Tilray (TLRY) the stock with the wildest gains so far this year.
Then, there’s Choom (CSE: CHOO; OTC: CHOOF) (CHOOM PROFILE), which just came to the market late last year and has remained outside the frenzy. It is an undervalued jewel with upside growth potential that rivals the best in the business.
In fact, Choom already has the confidence of Canada’s best MJ companies. Aurora Cannabis has invested $7 million recently, and VIVO (frmr. ABCann) has inked a supply agreement with Choom earlier this year.
Cracking Retail Wide Open: Choom (CSE: CHOO; OTC: CHOOF) (CHOOM PROFILE)
Every market has its oddities, and in this one, Choom stands out. It is “only” up 496% in the past year compared to 1,009% for HEXO Corp; 1,193% for Namaste, and 4,152% for Tilray.
The other big gainers worked the PR machines to make much more noise… and sometimes they were a lot more explicit about their plans. Tilray secured a well-publicized Nasdaq listing then got much-touted FDA approval to export cannabis to the US for research. The market reacted to repeated news releases as if the company had personally cured the world’s diseases. Namaste’s e-commerce model put it into the ultra-rich accessories market with worldwide sales of vapes, pens and other tools.
Knowing what each company “does” has been the key to big gains in pot stocks.
Choom has had a strategy from the beginning that was a little harder for investors to warm to—“acquire and develop growing and retail assets.” Well, who in the Canadian MJ universe wasn’t? Even Choom’s admirers have to admit that doesn’t sound very sexy, and until recently, it wasn’t very clear what it would mean. As the Canadian market waits for Recreational Marijuana Oct. 17th, 2018 - Retail assets like those of CHOOM have become valuable.
But now, Choom is on the verge of establishing a huge footprint in the retail market. It can point to four growing sites so far and a fifth location in the future that will be even larger. There’s a lot of good news in the pipeline for investors to discover.
Choom Focused on Fun Before Investors Were Ready
Another subtle point that shouldn’t be overlooked in Choom’s quiet beginning may be subtle, but it probably counts for something. That is Choom’s name and “good times” message, which spoke to its adult-market intent.
The Canadian marijuana stocks started out completely differently from US companies—they were all legal entities, approved and licensed by Health Canada. They appealed to investors who didn’t need to worry the companies they were backing could be raided and seized any moment, a fate that is still technically possible for US MJ companies. As if it to underscore this respectability, Canadian company names are very restrained: Emerald Health, Maricann, Organigram, Emblem, CannTrust….
Then there was Choom—named after the “Choom Gang” of friends who smoked pot, surfed and lived for the good times, Choom was not a medical stalwart. (Read the History of Choom) It was always looking forward to the adult market.
At last, with Canada officially opening adult-use marijuana on Oct. 17, investors are ready for Choom.
Choom Has Coast to Coast Coverage In Sight
So far, Choom has three growing facilities all in late-stage licensing approval and a fourth site under offer. The lack of licensed growing space meant that Choom wasn’t making news when the likes of Canopy Growth and Aphria were on everyone’s radar. But now, Choom’s approvals are in very late stage. Approvals should come within weeks.
Phase 1 of its building plans entails developing 37,300 sq. ft. of indoor growing space in British Columbia capable of producing 3,700 kg dried cannabis per year. In Phase 2, when it will add facilities on Vancouver Island to the BC operation, Choom expects to expand to 68,200 sq. ft. that can produce 6,500 kg of dried cannabis a year.
At a wholesale price of $2,000 per kilo that means $13 million in revenues with all four farms running. That’s a low projection. Supreme Cannabis Co. prices its product at $6-$7 per gram, three times as high[i]. Canopy Growth, selling at $8 a gram is four times as high. So $2,000 per kilo ($2 per gram) is an exceedingly safe benchmark[ii].
Farther out, Choom intends to add 700,000 sq. ft. of indoor and greenhouse space in British Columbia and it has another 120 acres in Saskatchewan lined up.
But it is the retail plan that makes Choom particularly attractive. Not just for investors…. That is also the reason that Canada’s second largest MJ company, Aurora Cannabis, just took a big stake in Choom.
Choom has established 52 retail locations in Saskatchewan, Alberta, and British Columbia so far. Quebec, Manitoba, and Ontario are in its sights next. It recently applied to Manitoba for a license that it expects to have in hand when adult marijuana sales begin on Oct. 17.
The Aurora Big DealInvestors may have overlooked Choom, but the industry and accredited investors who have been active in the background are well aware of its potential. In February, its $2.7 million private placement was oversubscribed. Then in June, its $10 million raise included a hefty $7 million investment by Aurora Cannabis. Aurora now holds about 6% of Choom stock.
Aurora has a history of buying out good prospects. So, a future buyout is definitely a potential with Choom but it’s not the most important point here.
Choom’s deal with Aurora is probably exactly what Aurora says it is—a strategic position. Choom has planted its flag firmly in the western provinces and is almost a sure-shot to acquire rights in the much more populous provinces of Manitoba, Ontario, and Quebec very soon. The company intends to have a coast-to-coast presence and is well on the way to achieving it. Aurora would like a piece of that.
Investors should consider Aurora’s move a high compliment from an industry leader. The two companies first connected through Aurora’s Aurora Pro platform, which provides services to the industry[iii] and allows Aurora to support craft growers and help them enter the market. Aurora invested in Choom with an insider’s eye.
Choom has high upside potential, solid contracts, an ambitious and growing retail footprint and big votes of confidence by industry insiders. For the moment, it also has a bargain price.
Please see full disclaimers at www.TheSeedInvestor.com applicable to all content provided by TSI, wherever published or re-published: http://theseedinvestor.com/about/disclaimer
Disclaimer: This release/advertorial is a commercial advertisement and is for general information purposes only. This release/advertorial does not constitute an offer or solicitation to buy or sell any securities or individualized investment advice. This is a native advertisement, meaning it is an informational paid marketing piece. THESEEDINVESTOR.com (TSI) makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website. Please review all investment decisions with a licensed investment advisor. TSI receives payments ranging from approximately $25,000 to $150,000 to publish and/or distribute advertisements on behalf of a company. TSI retains any excess sums after expenses as its compensation. TheSeedInvestor.com and its owners, operators and affiliates may benefit from any increase in the share prices of the profiled companies. TheSeedInvestor.com may be paid for services using options or free-trading shares. TheSeedInvestor.com and/or its owners, operators and affiliates may be selling shares of stock at the same time the profile (or other information) is being disseminated to potential investors; TheSeedInvestor.com will not advise when it or its affiliates decide to sell. Investors must make all investment decisions based on their own judgment of the market and the particular securities.
This advertorial contains forward-looking statements that involve risks and uncertainties. This advertorial contains or incorporates by reference forward-looking statements, including certain information with respect to plans and strategies of the featured company. As such, any statements contained herein or incorporated herein by reference that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, the words “believe(s),” “anticipate(s),” “plan(s),” “expect(s),” “project(s),” “will,” “make,” “told,” “could,” “might,” and similar expressions are intended to identify forward-looking statements. There are a number of important factors that could cause actual events or actual results of the company to differ materially from these indicated by such forward-looking statements. Certain statements contained herein are forward-looking statements as defined in Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Such statements include, without limitation, statements regarding business, financing, business trends, future operating revenues and expenses. There can be no assurance that such expectations will prove to be correct. Investors are cautioned that any forward-looking statements made by the company, or contained in this advertorial are not guarantees of future performance, and that the issuer’s actual results may differ materially from those set forth in the forward-looking statements. We undertake no obligation to update any statements made herein except as required by law. Differences in results can be caused by various factors including, but not limited to, the company’s ability to be able to successfully complete planned funding agreements, to successfully market its products in competitive industries or to effectively implement its business plan or strategies. To reiterate, information presented in this advertorial contains “forward-looking statements.” Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact and may be “forward-looking statements.” Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. More information on the company may be found at http://www.sec.gov where readers can review all public filings submitted by the company. TheSeedInvestor.com is not a certified financial analyst or licensed in the securities industry in any manner. The information in this advertorial is subjective opinion and may not be complete, accurate or current and was paid for, so this could create a conflict of interest.